Skip to main content

Baxter International



) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day up 1.3%. By the end of trading, Baxter International rose 85 cents (1.7%) to $52.09 on average volume. Throughout the day, 2.7 million shares of Baxter International exchanged hands as compared to its average daily volume of 3.1 million shares. The stock ranged in a price between $51.11-$52.18 after having opened the day at $51.11 as compared to the previous trading day's close of $51.24. Other companies within the Health Care sector that increased today were:

Aoxing Pharmaceutical Company



), up 34.9%,

Arena Pharmaceuticals



), up 28.7%,

Lincare Holdings



), up 23.4%, and

TheStreet Recommends




), up 21.5%.

  • ACTIVE STOCK TRADERS: Check out TheStreet's special offer for Real Money, headlined by Jim Cramer, now!

Baxter International Inc., through its subsidiaries, develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. Baxter International has a market cap of $28.59 billion and is part of the

health services

industry. The company has a P/E ratio of 13, equal to the average health services industry P/E ratio and below the S&P 500 P/E ratio of 17.7. Shares are up 3.6% year to date as of the close of trading on Tuesday. Currently there are 12 analysts that rate Baxter International a buy, no analysts rate it a sell, and five rate it a hold.

TheStreet Ratings rates Baxter International as a


. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, notable return on equity, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself.

On the negative front,

Omeros Corporation



), down 20%,

Osiris Therapeutics



), down 17.4%,

Dynacq Healthcare



), down 12%, and




), down 11.9%, were all losers within the health care sector with

Regeneron Pharmaceuticals



) being today's health care sector loser.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider

Health Care Select Sector SPDR



) while those bearish on the health care sector could consider

ProShares Ultra Short Health Care